Jennifer B. Damico - 27 Feb 2025 Form 4 Insider Report for PFIZER INC (PFE)

Role: SVP & Controller
Signature: /s/ Shanice A. Reid, by power of atty, for Jennifer B. Damico
Issuer symbol: PFE
Transactions as of: 27 Feb 2025
Net transactions value: -$84,374
Form type: 4
Filing time: 06 Mar 2025, 13:57:57 UTC
Previous filing: 03 Mar 2025
Next filing: 24 Feb 2026
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PFE	Common Stock	Tax liability	$19,549	-749	-2.5%	$26.10	29,761	27 Feb 2025	Direct	F1
transaction	PFE	Common Stock	Award	$0	+5,583	+64%	$0.000000	14,350	04 Mar 2025	Direct	F2
transaction	PFE	Common Stock	Sale	$64,825	-2,500	-17%	$25.93	11,850	04 Mar 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PFE	Stock Appreciation Rights	Award	$0	+47,511		$0.000000	47,511	04 Mar 2025	Common Stock	47,511	$25.75	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).
F2	The reported transaction constitutes the grant of restricted stock units, which are subject to certain vesting requirements.
F3	The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant.